<DOC>
	<DOC>NCT01498874</DOC>
	<brief_summary>The purpose of this study is to determine whether gevokizumab is effective in the treatment of moderate to severe acne vulgaris.</brief_summary>
	<brief_title>Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Diagnosis of moderate to severe acne vulgaris Acne vulgaris unresponsive to oral antibiotics Willingness to maintain current habits for facial cleaning, shaving, and application of cosmetics through the end of the study Use of medications or treatments from specified pretreatment time periods through the end of the study Beard, moustache, sideburns or other facial hair that may interfere with evaluation Other forms of acne History of malignancy within 5 years History of allergic or anaphylactic reactions to monoclonal antibodies History of tuberculosis History of chronic systemic infections Female subjects who are pregnant, planning to become pregnant Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>17 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Acne</keyword>
	<keyword>Acne Vulgaris</keyword>
</DOC>